Merck's plant gets European nod to make JnJ Covid-19 vaccine
New Delhi: The European Medicines Agency (EMA) said on Thursday it had approved U.S. drugmaker Merck & Co Inc's manufacturing site in West Point, Pennsylvania to make Johnson & Johnson's COVID-19 vaccine.
Earlier this year, Merck agreed to make its rival's shot, after scrapping two of its own experimental COVID-19 vaccines.
Also Read:JnJ plans to seek USFDA authorization for booster shot of Covid-19 vaccine
The U.S. government at that time invoked the Defense Production Act to help equip two Merck plants to make the J&J vaccine.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.